Podcast
Podcast
The Bioverge Podcast: Developing Next-Generation in Vivo Cell and Gene Therapies
David Johnson, Founder & CEO of GigaMune, sits down with Neil to discuss his company's efforts to develop in vivo cell and gene therapies to treat cancer and autoimmune conditions.
Continue Reading >
Podcast
The Bioverge Podcast: Addressing the Challenges of Chronic Liver Disease
Jack O’Meara, co-founder and CEO of Ochre Bio, sits down with Neil to discuss the large unmet health need created by chronic liver disease and the company’s efforts to develop RNA therapies address it.
Continue Reading >
Podcast
The Bioverge Podcast: Engineering Intelligence into Cell and Gene Therapies
Tim Lu, co-founder and CEO of Senti Bio, sits down with Neil to discuss how his company is using synthetic biology to engineer cell and gene therapies with programmable gene circuits to make therapies that are safer, more effective, and precise.
Continue Reading >
Podcast
The Bioverge Podcast: Changing Drug Discovery with Transomics
On this episode, Neil sits down with Samantha Dale Strasser, co-founder and chief scientific officer of Pepper Bio, to discuss the company’s computational drug discovery platform and how its transomics approach can lead to the discovery and development of safer and more effective drugs.
Continue Reading >
Podcast
The Bioverge Podcast: Accelerating Timelines and The Bioverge Podcast: Improving Outcomes with a Predictive Precision Medicine Platform
Matt De Silva, founder and executive chairman of Notable Labs, sits down with Neil to discuss his company’s predictive precision medicine platform and its move to leverage its platform to develop its own precision cancer therapies.
Continue Reading >
Podcast
The Bioverge Podcast: A Wall Street Veteran Discusses Where Biotech Has Been and What's Ahead
Dennis Purcell, founder of Aisling Capital and former managing director of the Life Sciences Investment Banking Group at Chase H&Q, sits down with Neil discuss where biotech has been and what's ahead for the sector.
Continue Reading >
Podcast
The Bioverge Podcast: Curing Blindness with Cell Therapy
On this episode, Arnaud Lacoste, Chief Scientific Officer of Aurion Biotech, sits down with Neil Littman to discuss the company’s experimental cell therapy to restore vision in patients with corneal endothelial disease.
Continue Reading >
Podcast
The Bioverge Podcast: From Bugs to Drugs
Kareem Barghouti, co-founder and CEO of VastBiome, sits down with Neil to discuss how his company is using AI to map the gut microbiome to discover novel therapies.
Continue Reading >
Podcast
The Bioverge Podcast: Forging a TechBio Culture
Viswa Colluru, founder and CEO of Enveda Bio sits down with Neil to discuss AI in drug development, and the challenges of managing and forging a TechBio culture.
Continue Reading >
Podcast
The Bioverge Podcast: Investing in the Bio-Based Future
Lindy Fishburne, managing partner of Breakout Ventures, sits down with Neil to discuss investing in seed- and early-stage bioscience companies, and what she learned working with entrepreneurial scientists at Breakout Labs.
Continue Reading >